Stochastic modeling of drug resistance in cancer

DOI10.1016/J.JTBI.2005.08.003zbMath1445.92143OpenAlexW1988414899WikidataQ46018277 ScholiaQ46018277MaRDI QIDQ2195074

Natalia L. Komarova

Publication date: 7 September 2020

Published in: Journal of Theoretical Biology (Search for Journal in Brave)

Full work available at URL: https://doi.org/10.1016/j.jtbi.2005.08.003

zbMATH Keywords

mathematical modelmulti-drug therapypre-existencetargeted drugstreatment success

Mathematics Subject Classification ID

Medical applications (general) (92C50) Applications of stochastic analysis (to PDEs, etc.) (60H30)

Related Items (20)

Mutation frequencies in a birth-death branching process ⋮ Exponentiality of first passage times of continuous time Markov chains ⋮ A comparison of mutation and amplification-driven resistance mechanisms and their impacts on tumor recurrence ⋮ Waiting times in a branching process model of colorectal cancer initiation ⋮ From the mathematical kinetic theory of active particles to multiscale modelling of complex biological systems ⋮ Modeling the dynamics of heterogeneity of solid tumors in response to chemotherapy ⋮ Inferring density-dependent population dynamics mechanisms through rate disambiguation for logistic birth-death processes ⋮ Optimal policies of non-cross-resistant chemotherapy on Goldie and Coldman's cancer model ⋮ Evolution of resistance to anti-cancer therapy during general dosing schedules ⋮ Stochastic modeling of cellular colonies with quiescence: an application to drug resistance in cancer ⋮ An elementary mathematical modeling of drug resistance in cancer ⋮ The fixed-size Luria-Delbrück model with a nonzero death rate ⋮ Modeling the chemotherapy-induced selection of drug-resistant traits during tumor growth ⋮ The impact of cell density and mutations in a model of multidrug resistance in solid tumors ⋮ Modeling continuous levels of resistance to multidrug therapy in cancer ⋮ Опухолевый рост и возможности математического моделирования системных процессов ⋮ An Evolutionary Model of Tumor Cell Kinetics and the Emergence of Molecular Heterogeneity Driving Gompertzian Growth ⋮ A quasi birth-and-death model for tumor recurrence ⋮ The impact of competition between cancer cells and healthy cells on optimal drug delivery ⋮ Scaling solution in the large population limit of the general asymmetric stochastic Luria-Delbrück evolution process

Cites Work

• Unnamed Item
• Unnamed Item
• Unnamed Item
• Unnamed Item
• The mathematical modelling of adjuvant chemotherapy scheduling: incorporating the effects of protocol rest phases and pharmacokinetics
• Role of optimal control theory in cancer chemotherapy
• A model for the resistance of tumor cells to cancer chemotherapeutic agents
• A theoretical analysis of interval drug dosing for cell-cycle-phase- specific drugs
• Time-continuous branching walk models of unstable gene amplification
• The effect of heterogeneity on optimal regimens in cancer chemotherapy
• A mathematical model to study the effects of drug resistance and vasculature on the response of solid tumors to chemotherapy
• Optimal control for a stochastic model of cancer chemotherapy
• A stochastic model for the origin and treatment of tumors containing drug-resistant cells
• Cancer chemotherapy optimization under evolving drug resistance.
• The application of mathematical modelling to aspects of adjuvant chemotherapy scheduling
• Growth of nonnecrotic tumors in the presence and absence of inhibitors
• The dynamics of gene amplification described as a multitype compartmental model and as a branching process

This page was built for publication: Stochastic modeling of drug resistance in cancer